MK-0677 (ibutamoren mesylate) for the treatment of patients recovering from hip fracture: A multicenter, randomized, placebo-controlled phase IIb study
Abraham Adunsky*, Julie Chandler, Norman Heyden, Jeannine Lutkiewicz, Boyd B. Scott, Yuliya Berd, Nancy Liu, Dimitris A. Papanicolaou
Research output: Contribution to journal › Article › peer-review
55Scopus
citations
Fingerprint
Dive into the research topics of 'MK-0677 (ibutamoren mesylate) for the treatment of patients recovering from hip fracture: A multicenter, randomized, placebo-controlled phase IIb study'. Together they form a unique fingerprint.